Pretreatment with aminophylline reduces release of Troponin I and neutrophil activation in the myocardium of patients undergoing cardioplegic arrest

European Journal of Cardio-thoracic Surgery

Volumn 31, Issue 3, 2007, Pages 360-365

  Luo, Wan Jun ^a   Qian, Jian Fang ^a   Jiang, Hai He ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Aminophylline; Myocardium protection; Neutrophil; Tropnin I

Indexed keywords

AMINOPHYLLINE; CYCLIC AMP; MYELOPEROXIDASE; TROPONIN I;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CARDIOPLEGIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE PERFUSION; HEART PROTECTION; HUMAN; HUMAN TISSUE; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROTEIN SECRETION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AMINOPHYLLINE; CARDIOTONIC AGENTS; CYCLIC AMP; DOUBLE-BLIND METHOD; FEMALE; HEART; HEART ARREST, INDUCED; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTRAOPERATIVE CARE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYOCARDIUM; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEROXIDASE; RHEUMATIC HEART DISEASE; TREATMENT OUTCOME; TROPONIN I;

EID: 33847312821     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.11.042     Document Type: Article

References (21)

1. Valen G.V., Paulsson G., and Vaage J. Induction of inflammatory mediators during reperfusion of the human heart Ann. Thorac Surg 71 (2001) 226-232
2. Barnes P.J. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med 167 (2003) 813-818
3. Luo W.J., Ling X., and Huang R.M. Effects of aminophylline on cytokines and pulmonary function in patients undergoing valve replacement. Euro J Cardiothoracic Surg 25 (2004) 766-771
4. Sullivan P., Bekir S., Jaffar Z., Page C., Jeffery P., and Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 343 (1994) 1006-1008
5. Mahomed A.G., Theron A.J., Anderson R., and Feldman C. Anti-oxidative effects of theophylline on human neutrophils involve cyclic nucleotides and protein kinase A. Inflammation 22 (1998) 545-557
6. Yasui K., Agematsu K., Shinozaki K., Hokibara S., Nagumo H., Yamada S., Kobayashi N., and Komiyama A. Effects of theophylline on human eosinophil functions: comparative study with neutrophil functions. J Leukoc Biol 68 (2000) 194-200
7. Ulus A.T., Gökçe P., Özgencil E., Yildiz U., Ibrişim E., and Katircǧlu S.F. Beneficial Effects of aminophylline on ischemia-reperfusion in isolated rabbit heart. Asian Cardiovasc Thorac Ann 7 (1999) 96-100
8. Kaplan S., Ozisik K., Morgan J.A., and Dogan R. Measurement of troponin T and I to detect cardioprotective effect of aminophylline during coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 30 2 (2003) 310-315
9. Kobayashi T., Sugawara Y., Ohkubo T., Imamura H., and Makuuchi M. Effects of amrinone on hepatic ischemia-reperfusion injury in rats. J Hepatol 37 (2002) 31-38
10. Mullane K.M., Kraemer R., and Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14 (1985) 157-167
11. Paparella D., Cappabianca G., Visicchio G., Galeone A., Marzovillo A., Gallo N., Memmola C., and Schinosa Lde L. Cardiac Troponin I release after coronary artery bypass grafting operation: effects on operative and midterm survival. Ann. Thorac. Surg 80 (2005) 1758-1764
12. Greenson N., Macoviak J., Krishnaswamy P., Morrisey R., James C., Clopton P., Fitzgerald R., and Maisel A.S. Usefulness of cardiac Troponin I in patients undergoing open-heart surgery. Am Heart J 141 (2001) 447-455
13. Rinder C. Cellular inflammatory response and clinical outcome in cardiac surgery. Curr Opin Anaesthesiol 19 (2006) 65-68
14. Jordan J.E., and Zhao Z.-Q. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43 (1999) 860-887
15. Casnocha S.A., Eskin S.G., Hall E.R., and MacInire L.V. Permeability of human endothelial monolayers: effect of vasoactive agonists and camp. J Appl Physiol 67 (1989) 1997-2005
16. Yasui K., Hu B., Nakazawa T., Agematsu K., and Komiyama A. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest 100 (1997) 1677-1684
17. Deree J., Lall R., Melbostad H., Grant M., Hoyt D.B., and Coimbra R. Neutrophil degranulation and the effects of phosphodiesterase inhibition. J Surg Res 133 (2006) 22-28
18. Ito K., Lim S., Caramori G., Cosio B., Chung K.F., Adcock I.M., and Barnes P.J. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci 99 (2002) 8921-8926
19. Kobayashi M., Nasuhara Y., Betsuyaku T., Shibuya E., Tanino Y., Tanino M., Takamura K., Nagai K., Hosokawa T., and Nishimura M. Effect of low-dose theophylline on airway inflammation in COPD. Respirology 9 (2004) 249-254
20. Alvarez A., Piqueras L., Blazquez M.A., and Sanz M.J. Cyclic AMP elevating agents and nitric oxide modulate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. J Pharmacol 133 (2001) 485-494
21. Janelle G.M., Urdaneta F., Blas M.L., Shryock J., Tang Y.S., Martin T.D., and Lobato E.B. Inhibition of phosphodiesterase type III before aortic cross-clamping preserves intramyocardial cyclic adenosine monophosphate during cardiopulmonary bypass. Anesth Analg 92 (2001) 1377-1383